Pre-order Enquiry
Request Free Sample
Global Fusidic Acid Market Research Report 2022
SKU ID : QYR-21051303 | Publishing Date : 09-Jun-2022
Request Sample
Request Customization
Check Discounts
The Fusidic Acid industry can be broken down into several segments, Fusidic Acid under 97%, Fusidic Acid 97%-99%, etc.
Across the world, the major players cover LEO Pharma, Ercros S.A., etc.
Fusidic acid is an antibiotic that is often used topically in creams and eyedrops but may also be given systemically as tablets or injections.
Due to the COVID-19 pandemic, the global Fusidic Acid market size is estimated to be worth US$ 183.4 million in 2021 and is forecast to a readjusted size of US$ 290.3 million by 2028 with a CAGR of 6.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Fusidic Acid market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Fusidic Acid landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The industry's leading producers are LEO Pharma and Ercros S.A. the combined share of revenue in 2019 is 73.27%.
This report focuses on Fusidic Acid volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Fusidic Acid market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: Europe, China and India, etc.
Global Fusidic Acid Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Fusidic Acid under 97%
Fusidic Acid 97%-99%
Fusidic Acid above 99%
Segment by Application
Creams and Ointments
Eyedrops
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
LEO Pharma
Ercros S.A.
Contay Biotechnology
Joyang Labs
HELM AG
Hoyoo Chemical
Wellona Pharma
Across the world, the major players cover LEO Pharma, Ercros S.A., etc.
Fusidic acid is an antibiotic that is often used topically in creams and eyedrops but may also be given systemically as tablets or injections.
Due to the COVID-19 pandemic, the global Fusidic Acid market size is estimated to be worth US$ 183.4 million in 2021 and is forecast to a readjusted size of US$ 290.3 million by 2028 with a CAGR of 6.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Fusidic Acid market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Fusidic Acid landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The industry's leading producers are LEO Pharma and Ercros S.A. the combined share of revenue in 2019 is 73.27%.
This report focuses on Fusidic Acid volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Fusidic Acid market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: Europe, China and India, etc.
Global Fusidic Acid Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Fusidic Acid under 97%
Fusidic Acid 97%-99%
Fusidic Acid above 99%
Segment by Application
Creams and Ointments
Eyedrops
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
LEO Pharma
Ercros S.A.
Contay Biotechnology
Joyang Labs
HELM AG
Hoyoo Chemical
Wellona Pharma
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
